Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complement activation following oxidative stress.

C D Collard1, R Lekowski, J E Jordan

  • 1Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Molecular Immunology
|March 4, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Meaningful engagement of lived experience in diabetes research and health service improvement: A rapid review of barriers to and enablers for community involvement among adults with type 2 diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same author

Health Equity: What the Neuroradiologist Needs to Know.

AJNR. American journal of neuroradiology·2022
Same author

Phase-coherent sensing of the center-of-mass motion of trapped-ion crystals.

Physical review. A·2022
Same author

The American Society of Neuroradiology: Cultivating a Diverse and Inclusive Culture to Build a Stronger Organization.

AJNR. American journal of neuroradiology·2021
Same author

Headache and Neuroimaging: Why We Continue to Do It.

AJNR. American journal of neuroradiology·2020
Same author

Platelet thrombus formation in eHUS is prevented by anti-MBL2.

PloS one·2019

Complement activation is key in oxidative stress inflammation. Ongoing trials with complement inhibitors may offer new treatments for human diseases, but more research is needed.

Area of Science:

  • Immunology
  • Cellular Biology
  • Pathophysiology

Background:

  • The complement system plays a crucial role in inflammatory responses triggered by oxidative stress.
  • Oxidative stress is implicated in various disease states, highlighting the need to understand inflammatory mediators.
  • Current understanding of complement's role in disease is incomplete, particularly concerning endothelial cell activation.

Purpose of the Study:

  • To explore the mechanisms of complement activation on endothelial cells following oxidative stress.
  • To identify the specific ligand for mannose-binding lectin (MBL) on endothelial cells in the context of oxidative stress.
  • To evaluate the potential therapeutic benefits of inhibiting MBL compared to other complement inhibitors.

Main Methods:

  • Investigating complement activation pathways in cellular and animal models of oxidative stress.

Related Experiment Videos

  • Utilizing in vitro assays to identify MBL ligands on stressed endothelial cells.
  • Comparing the efficacy of MBL inhibition with established complement inhibitors (e.g., sCR1, anti-C5 mAbs) in preclinical models.

    • Main Results:

    • Evidence suggests complement activation is a significant factor in oxidative stress-induced inflammation.
    • Clinical trials are exploring the therapeutic potential of novel complement inhibitors.
    • Key questions remain regarding the precise mechanisms of complement activation and MBL function in this context.

    Conclusions:

    • Complement inhibition shows promise as a therapeutic strategy for diseases involving oxidative stress and inflammation.
    • Further research is essential to elucidate the specific roles of MBL and other complement components in endothelial cell activation.
    • Understanding these pathways will guide the development of targeted therapies for human diseases.